Breast cancer claims younger black female lives. If so, when should the screening begin?

Published Date: 26 Apr 2023

Once a woman turns 40, experts advise that she at the very least think about starting a breast cancer screening program. According to a recent study, Black women need this advice above all others.

Read Full News

Latest News



Todays Updates


FDA Grants Priority Review to Efgartigimod, First Potential Therapy for Seronegative Myasthenia Gravis Victoria Johnson


argenx's efgartigimod-alfa therapy was approved for seropositive generalized myasthenia gravis in 2021.

Early Opicapone Initiation in Parkinson Leads to Continued Long-Term Therapeutic Benefits Marco Meglio


Early initiation of opicapone significantly reduces OFF time and enhances ON time in patients with recently diagnosed Parkinson's disease, improving overall treatment outcomes.

FDA Requests HOPE-3 Clinical Study Report for Deramiocel BLA in DMD Cardiomyopathy Isabella Ciccone, MPH


The FDA requested the full data from the phase 3 HOPE-3 study as part of its review of the biologics license application for deramiocel, which Capricor plans to submit in February 2026.

Low-Dose Opioids Show Long-Term Dose Stability, Effectiveness in Augmented Restless Legs Syndrome Louie Pasculli


A five-year analysis from the National RLS Opioid Registry found that most patients with dopamine agonist augmented restless legs syndrome maintained stable, low-dose opioid therapy with sustained symptom control.

Personalized Care Improvements Identified for Older Patients with Skin Cancer


Personalized Care Improvements Identified for Older Patients with Skin Cancer

New Findings on Acne Incidence in Transgender Individuals, With Howa Yeung, MD, MSc


New Findings on Acne Incidence in Transgender Individuals, With Howa Yeung, MD, MSc

What to Expect at the 2026 Maui Derm Conference


What to Expect at the 2026 Maui Derm Conference

Todays Updates


FDA Grants Priority Review to Efgartigimod, First Potential Therapy for Seronegative Myasthenia Gravis Victoria Johnson


argenx's efgartigimod-alfa therapy was approved for seropositive generalized myasthenia gravis in 2021.

Early Opicapone Initiation in Parkinson Leads to Continued Long-Term Therapeutic Benefits Marco Meglio


Early initiation of opicapone significantly reduces OFF time and enhances ON time in patients with recently diagnosed Parkinson's disease, improving overall treatment outcomes.

FDA Requests HOPE-3 Clinical Study Report for Deramiocel BLA in DMD Cardiomyopathy Isabella Ciccone, MPH


The FDA requested the full data from the phase 3 HOPE-3 study as part of its review of the biologics license application for deramiocel, which Capricor plans to submit in February 2026.

Low-Dose Opioids Show Long-Term Dose Stability, Effectiveness in Augmented Restless Legs Syndrome Louie Pasculli


A five-year analysis from the National RLS Opioid Registry found that most patients with dopamine agonist augmented restless legs syndrome maintained stable, low-dose opioid therapy with sustained symptom control.

Personalized Care Improvements Identified for Older Patients with Skin Cancer


Personalized Care Improvements Identified for Older Patients with Skin Cancer

New Findings on Acne Incidence in Transgender Individuals, With Howa Yeung, MD, MSc


New Findings on Acne Incidence in Transgender Individuals, With Howa Yeung, MD, MSc

What to Expect at the 2026 Maui Derm Conference


What to Expect at the 2026 Maui Derm Conference

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Except for Black Patients, the Rates of Gallbladder Cancer Are Stable or Declining.

2.

Study: For predicting breast cancer, AI performs better than traditional risk models.

3.

For patients with breast cancer receiving chemotherapy, exercise may help lessen the long-term side effects.

4.

Year in Review: Chronic Lymphocytic Leukemia

5.

Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot